Growth Metrics

Healthequity (HQY) Net Cash Flow (2016 - 2026)

Healthequity has reported Net Cash Flow over the past 14 years, most recently at $9.7 million for Q1 2026.

  • For Q1 2026, Net Cash Flow rose 136.88% year-over-year to $9.7 million; the TTM value through Jan 2026 reached $23.0 million, up 121.27%, while the annual FY2026 figure was $23.0 million, 121.27% up from the prior year.
  • Net Cash Flow for Q1 2026 was $9.7 million at Healthequity, up from $4.8 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $75.7 million in Q3 2024 and troughed at -$423.7 million in Q1 2022.
  • A 5-year average of -$19.4 million and a median of $9.7 million in 2026 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: plummeted 1538.91% in 2022 and later skyrocketed 313.73% in 2023.
  • Year by year, Net Cash Flow stood at $33.3 million in 2022, then soared by 31.24% to $43.7 million in 2023, then plummeted by 110.82% to -$4.7 million in 2024, then soared by 201.44% to $4.8 million in 2025, then skyrocketed by 101.5% to $9.7 million in 2026.
  • Business Quant data shows Net Cash Flow for HQY at $9.7 million in Q1 2026, $4.8 million in Q4 2025, and $16.6 million in Q3 2025.